WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026.
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the cu...
The Chemours Company (NYSE:CC ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO & Director Shane W.
Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Despite legacy risks and sub-par credit, Chemours' leadership in low-impact refrigerants and proprietary titanium technology sets it apart from competitors. Current market and analyst sentiment underestimates Chemours' potential, with forecasts showing strong EPS and EBITDA growth through 2026-...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.